Evidence map›Paper›PMID 25878273›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.

Abraham Martín, Boguslaw Szczupak, Vanessa Gómez-Vallejo, Maria Domercq, Ainhoa Cano, Daniel Padro, Clara Muñoz, Makoto Higuchi, Carlos Matute, Jordi Llop

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Role of Microglia in Stroke.Advances in neurobiology · 2024
    Review
  4. Article
  5. Abnormal [Synapse (New York, N.Y.) · 2023
    Article
  6. Article
  7. Review
  8. Nicotine Activating αMolecular neurobiology · 2022
    Article
  9. TSPO imaging in animal models of brain diseases.European journal of nuclear medicine and molecular imaging · 2021
    Review
  10. A Modest Increase inBiological psychiatry. Cognitive neuroscience and neuroimaging · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Iranian journal of basic medical sciences · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Theranostics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Abraham MartínMolecular Imaging Unit and amartin@cicbiomagune.es.
Boguslaw SzczupakMolecular Imaging Unit and.ORCID http://orcid.org/0000-0002-2098-1577
Vanessa Gómez-VallejoRadiochemistry Department, Molecular Imaging Unit, CIC biomaGUNE, San Sebastián, Guipuzcoa, Spain.
Maria DomercqDepartment of Neurociences, University of the Basque Country, 48940 Leioa, Spain, Achucarro Basque Center for Neuroscience-UPV/EHU, 48170 Zamudio, Spain, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain, and.
Ainhoa CanoMolecular Imaging Unit and.
Daniel PadroMolecular Imaging Unit and.
Clara MuñozMolecular Imaging Unit and.
Makoto HiguchiMolecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.
Carlos MatuteDepartment of Neurociences, University of the Basque Country, 48940 Leioa, Spain, Achucarro Basque Center for Neuroscience-UPV/EHU, 48170 Zamudio, Spain, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain, and.
Jordi LlopRadiochemistry Department, Molecular Imaging Unit, CIC biomaGUNE, San Sebastián, Guipuzcoa, Spain.
ABT Molecular Imaging (United States) · USCIC biomaGUNE · ESUniversity of the Basque Country · ESImaging Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PET imaging of nicotinic acetylcholine receptors (nAChRs) could become an effective tool for the diagnosis and therapy evaluation of neurologic diseases. Despite this, the role of nAChRs α4β2 receptors after brain diseases such as cerebral ischemia and its involvement in inflammatory reaction is still largely unknown. To investigate this, we performed in parallel in vivo magnetic resonance imaging (MRI) and positron emission tomography (PET) with 2[(18)F]-fluoro-A85380 and [(11)C]PK11195 at 1, 3, 7, 14, 21, and 28 d after middle cerebral artery occlusion (MCAO) in rats. In the ischemic territory, PET with 2[(18)F]-fluoro-A85380 and [(11)C]PK11195 showed a progressive binding increase from days 3-7, followed by a progressive decrease from days 14-28 after cerebral ischemia onset. Ex vivo immunohistochemistry for the nicotinic α4β2 receptor and the mitochondrial translocator protein (18 kDa) (TSPO) confirmed the PET findings and demonstrated the overexpression of α4β2 receptors in both microglia/macrophages and astrocytes from days 7-28 after experimental ischemic stroke. Likewise, the role played by α4β2 receptors on neuroinflammation was supported by the increase of [(11)C]PK11195 binding in ischemic rats treated with the α4β2 antagonist dihydro-β-erythroidine hydrobromide (DHBE) at day 7 after MCAO. Finally, both functional and behavioral testing showed major impaired outcome at day 1 after ischemia onset, followed by a recovery of the sensorimotor function and dexterity from days 21-28 after experimental stroke. Together, these results suggest that the nicotinic α4β2 receptor could have a key role in the inflammatory reaction underlying cerebral ischemia in rats.

Indexed as

Positron-Emission TomographyAmidesAnimalsBrainCD11b AntigenCell CountDihydro-beta-ErythroidineDisease Models, AnimalEncephalitisFluorodeoxyglucose F18Glial Fibrillary Acidic ProteinInfarction, Middle Cerebral ArteryIsoquinolinesMagnetic Resonance ImagingMaleMental DisordersAmidesCD11b AntigenDihydro-beta-ErythroidineFluorodeoxyglucose F18Glial Fibrillary Acidic ProteinIsoquinolinesnicotinic receptor alpha4beta2(R)-(11C)1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamideReceptors, Nicotinic[11C]PK111952[18F]-fluoro-A85380cerebral ischemiaPETTSPOα4β2

Identifiers

PMID25878273
PMCPMC6605174
OpenAlexW2084034568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.